Quantitative Systematic Strategies LLC Biomarin Pharmaceutical Inc Transaction History

Quantitative Systematic Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$74.73 - $90.69 $325,822 - $395,408	-4,360 Reduced 35.28%	8,000 $604,000
Q4 2020 Feb 09, 2021	BUY	$72.61 - $90.2 $80,451 - $99,941	1,108 Added 9.85%	12,360 $1.08 Million
Q3 2020 Nov 09, 2020	SELL	$71.87 - $131.03 $120,813 - $220,261	-1,681 Reduced 13.0%	11,252 $856,000
Q2 2020 Aug 04, 2020	BUY	$79.55 - $124.22 $419,546 - $655,136	5,274 Added 68.86%	12,933 $1.6 Million
Q1 2020 May 06, 2020	SELL	$71.37 - $96.85 $274,203 - $372,097	-3,842 Reduced 33.41%	7,659 $647,000
Q4 2019 Feb 11, 2020	SELL	$64.27 - $86.37 $128,282 - $172,394	-1,996 Reduced 14.79%	11,501 $972,000
Q3 2019 Nov 07, 2019	BUY	$67.4 - $85.11 $909,697 - $1.15 Million	13,497 New	13,497 $910,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.